Filing Details
- Accession Number:
- 0001203311-23-000096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-30 19:07:36
- Reporting Period:
- 2023-08-28
- Accepted Time:
- 2023-08-30 19:07:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1361966 | B Vaughn Himes | 21823 30Th Drive Se Bothell WA 98021 | Chief Technical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-28 | 937 | $0.00 | 53,605 | No | 4 | A | Direct | |
Common Stock | Disposition | 2023-08-29 | 371 | $206.00 | 53,234 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 119,471 | Indirect | by Trust |
Footnotes
- The performance criteria for these restricted stock units were met. These restricted stock units became fully vested on 8/28/2023.
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/3/2020 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).